Axel Stuart Merseburger, MD, PhD, explained that with TKIs like axitinib, it is necessary for oncology nurses to spend time ...

Oncology nurses and APPs play a key role in educating patients on BREAKWATER study findings and their impact on BRAF-mutant ...

The FDA approved tislelizumab-jsgr (Tevimbra) with platinum chemotherapy as a first-line treatment for adults with ...

Oncology nurses are familiar with the concept of financial toxicity, which refers to the significant financial burden cancer ...

Hazards of the LA wildfires necessitate awareness that first responders and those central to the fires may be at risk for ...

One of the hardest lessons learned occurred after I inadvertently failed at communication and education before transferring a ...

Staying up to date with data from trials and information from organizations dedicated to cancer research is crucial for oncology nurses and APPs.

Real-World Data Back First-Line Avelumab and Axitinib in Advanced RCC ...

For patients with relapsed BRCA-mutated ovarian carcinoma, rucaparib produced a median OS of 19.4 months vs 25.4 months with ...

Real-World Data Back First-Line Avelumab and Axitinib in Advanced RCC ...

Real-World Data Back First-Line Avelumab and Axitinib in Advanced RCC ...

Panelists discuss how emerging treatments, digital health tools, and enhanced care coordination could streamline disease ...